[1]
|
NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 102-113 AND 267-273.
TISSUE=Teratocarcinoma;
PubMed=9418896 [NCBI, ExPASy, EBI, Israel, Japan]
Pluk H.,
Soffner J.,
Luehrmann R.,
van Venrooij W.J.;
"cDNA cloning and characterization of the human U3 small nucleolar ribonucleoprotein complex-associated 55-kilodalton protein.";
Mol. Cell. Biol. 18:488-498(1998).
|
[2]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain, and Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[3]
|
INTERACTION WITH U3 SNRNA.
DOI=10.1093/nar/28.18.3462; PubMed=10982864 [NCBI, ExPASy, EBI, Israel, Japan]
Lukowiak A.A.,
Granneman S.,
Mattox S.A.,
Speckmann W.A.,
Jones K.,
Pluk H.,
van Venrooij W.J.,
Terns R.M.,
Terns M.P.;
"Interaction of the U3-55k protein with U3 snoRNA is mediated by the box B/C motif of U3 and the WD repeats of U3-55k.";
Nucleic Acids Res. 28:3462-3471(2000).
|
[4]
|
INTERACTION WITH U3 SNRNA.
DOI=10.1074/jbc.M206631200; PubMed=12381732 [NCBI, ExPASy, EBI, Israel, Japan]
Granneman S.,
Pruijn G.J.M.,
Horstman W.,
van Venrooij W.J.,
Luehrmann R.,
Watkins N.J.;
"The hU3-55K protein requires 15.5K binding to the box B/C motif as well as flanking RNA elements for its association with the U3 small nucleolar RNA in Vitro.";
J. Biol. Chem. 277:48490-48500(2002).
|
[5]
|
IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
DOI=10.1091/mbc.E02-05-0271; PubMed=12429849 [NCBI, ExPASy, EBI, Israel, Japan]
Scherl A.,
Coute Y.,
Deon C.,
Calle A.,
Kindbeiter K.,
Sanchez J.-C.,
Greco A.,
Hochstrasser D.F.,
Diaz J.-J.;
"Functional proteomic analysis of human nucleolus.";
Mol. Biol. Cell 13:4100-4109(2002).
|
[6]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-51 AND SER-53, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[7]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-51; SER-53 AND SER-57, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0805139105; PubMed=18669648 [NCBI, ExPASy, EBI, Israel, Japan]
Dephoure N.,
Zhou C.,
Villen J.,
Beausoleil S.A.,
Bakalarski C.E.,
Elledge S.J.,
Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
|
[8]
|
VARIANTS [LARGE SCALE ANALYSIS] GLY-8 AND GLU-342.
DOI=10.1126/science.1133427; PubMed=16959974 [NCBI, ExPASy, EBI, Israel, Japan]
Sjoeblom T.,
Jones S.,
Wood L.D.,
Parsons D.W.,
Lin J.,
Barber T.D.,
Mandelker D.,
Leary R.J.,
Ptak J.,
Silliman N.,
Szabo S.,
Buckhaults P.,
Farrell C.,
Meeh P.,
Markowitz S.D.,
Willis J.,
Dawson D.,
Willson J.K.V.,
Gazdar A.F.,
Hartigan J.,
Wu L.,
Liu C.,
Parmigiani G.,
Park B.H.,
Bachman K.E.,
Papadopoulos N.,
Vogelstein B.,
Kinzler K.W.,
Velculescu V.E.;
"The consensus coding sequences of human breast and colorectal cancers.";
Science 314:268-274(2006).
|
|